TY - JOUR
T1 - Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline
AU - Crouser, E.D.
AU - Maier, L.A.
AU - Wilson, K.C.
AU - Bonham, C.A.
AU - Morgenthau, A.S.
AU - Patterson, K.C.
AU - Abston, E.
AU - Bernstein, R.C.
AU - Blankstein, R.
AU - Chen, E.S.
AU - Culver, D.A.
AU - Drake, W.
AU - Drent, M.
AU - Gerke, A.K.
AU - Ghobrial, M.
AU - Govender, P.
AU - Hamzeh, N.
AU - James, W.E.
AU - Judson, M.A.
AU - Kellermeyer, L.
AU - Knight, S.
AU - Koth, L.L.
AU - Poletti, V.
AU - Raman, S.V.
AU - Tukey, M.H.
AU - Westney, G.E.
AU - Baughman, R.P.
AU - American Thoracic Society Assembly on Clinical Problems
N1 - Funding Information:
Supported by the American Thoracic Society.
Publisher Copyright:
Copyright © 2020 by the American Thoracic Society
PY - 2020/4/15
Y1 - 2020/4/15
N2 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease. There are no universally accepted measures to determine if each diagnostic criterion has been satisfied; therefore, the diagnosis of sarcoidosis is never fully secure.Methods: Systematic reviews and, when appropriate, meta-analyses were performed to summarize the best available evidence. The evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation approach and then discussed by a multidisciplinary panel. Recommendations for or against various diagnostic tests were formulated and graded after the expert panel weighed desirable and undesirable consequences, certainty of estimates, feasibility, and acceptability.Results: The clinical presentation, histopathology, and exclusion of alternative diagnoses were summarized. On the basis of the available evidence, the expert committee made 1 strong recommendation for baseline serum calcium testing, 13 conditional recommendations, and 1 best practice statement. All evidence was very low quality.Conclusions: The panel used systematic reviews of the evidence to inform clinical recommendations in favor of or against various diagnostic tests in patients with suspected or known sarcoidosis. The evidence and recommendations should be revisited as new evidence becomes available.
AB - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease. There are no universally accepted measures to determine if each diagnostic criterion has been satisfied; therefore, the diagnosis of sarcoidosis is never fully secure.Methods: Systematic reviews and, when appropriate, meta-analyses were performed to summarize the best available evidence. The evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation approach and then discussed by a multidisciplinary panel. Recommendations for or against various diagnostic tests were formulated and graded after the expert panel weighed desirable and undesirable consequences, certainty of estimates, feasibility, and acceptability.Results: The clinical presentation, histopathology, and exclusion of alternative diagnoses were summarized. On the basis of the available evidence, the expert committee made 1 strong recommendation for baseline serum calcium testing, 13 conditional recommendations, and 1 best practice statement. All evidence was very low quality.Conclusions: The panel used systematic reviews of the evidence to inform clinical recommendations in favor of or against various diagnostic tests in patients with suspected or known sarcoidosis. The evidence and recommendations should be revisited as new evidence becomes available.
KW - cardiac involvement
KW - cardiac sarcoidosis
KW - endobronchial ultrasound
KW - endobronchial ultrasound biopsy
KW - granuloma
KW - late gadolinium enhancement
KW - ocular sarcoidosis
KW - positron-emission-tomography
KW - pulmonary hypertension
KW - pulmonary-hypertension
KW - rare lung disease
KW - renal sarcoidosis
KW - suspected stage-i
KW - transbronchial needle aspiration
KW - vitamin-d
KW - VITAMIN-D
KW - TRANSBRONCHIAL NEEDLE ASPIRATION
KW - ENDOBRONCHIAL ULTRASOUND
KW - PULMONARY-HYPERTENSION
KW - OCULAR SARCOIDOSIS
KW - SUSPECTED STAGE-I
KW - LATE GADOLINIUM ENHANCEMENT
KW - CARDIAC INVOLVEMENT
KW - POSITRON-EMISSION-TOMOGRAPHY
KW - RENAL SARCOIDOSIS
U2 - 10.1164/rccm.202002-0251ST
DO - 10.1164/rccm.202002-0251ST
M3 - Article
C2 - 32293205
SN - 1073-449X
VL - 201
SP - E26-E51
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 8
ER -